Loading...
Loading...
India's amino imports from CHINA total $1.8M across 114 shipments from 15 foreign suppliers. ZHEJIANG KANGLE PHARMACEUTICAL CO LTD leads with $799.0K in import value; the top 5 suppliers together control 92.7% of this origin. Leading Indian buyers include APOTEX RESEARCH PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for amino — a diversified sourcing base with multiple active suppliers from CHINA.

ZHEJIANG KANGLE PHARMACEUTICAL CO LTD is the leading Amino supplier from CHINA to India, with import value of $799.0K across 5 shipments. The top 5 suppliers — ZHEJIANG KANGLE PHARMACEUTICAL CO LTD, ZHEJIANG KANGLE PHARMACEUTICAL CO., LTD, FRESENIUS KABI (SINGAPORE) PTE LTD., FRESENIUS KABI ASIA PACIFIC LTD, ABCLONAL BIOTECHNOLOGY CO.LTD — collectively account for 92.7% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ZHEJIANG KANGLE PHARMACEUTICAL CO LTD | $799.0K | 5 | 44.2% |
| 2 | ZHEJIANG KANGLE PHARMACEUTICAL CO., LTD | $423.5K | 3 | 23.4% |
| 3 | FRESENIUS KABI (SINGAPORE) PTE LTD. | $301.0K | 3 | 16.6% |
| 4 | FRESENIUS KABI ASIA PACIFIC LTD | $95.3K | 2 | 5.3% |
| 5 | ABCLONAL BIOTECHNOLOGY CO.LTD | $58.4K | 39 | 3.2% |
| 6 | AB CLONAL BIOTECHNOLOGY CO,.LTD | $51.0K | 25 | 2.8% |
| 7 | AB CLONAL BIOTECHNOLOGY CO LIMITED | $22.2K | 9 | 1.2% |
| 8 | JIANGSU TIANHE PHARMACEUTICAL CO., LTD. | $13.8K | 1 | 0.8% |
| 9 | ZHEJIANG GUOBANG PHARMACEUTICAL | $11.3K | 1 | 0.6% |
| 10 | AB CLONAL BIOTECHNOLOGY CO.LIMITED | $10.0K | 1 | 0.6% |
| 11 | SUZHOU ERYE PHARMACEUTICAL CO,LTD | $5.5K | 1 | 0.3% |
| 12 | ABCLONAL BIOTECHNOLOGY CO LTD | $5.4K | 6 | 0.3% |
| 13 | AB CLONAL BIOTECHNOLOGY CO LTD | $5.1K | 4 | 0.3% |
| 14 | ABCLONAL BIOTECHNOLOGY CO LIMITED | $3.7K | 5 | 0.2% |
| 15 | AB CLONAL BIOTECHNOLOGY CO,.LIMITED | $2.5K | 2 | 0.1% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | APOTEX RESEARCH PRIVATE LIMITED | $1.2M | 8 | 67.6% |
| 2 | FRESENIUS KABI INDIA PRIVATE LIMITED | $396.3K | 5 | 21.9% |
| 3 | BIO GENOMICS ASIA | $158.4K | 91 | 8.8% |
| 4 | INTAS PHARMACEUTICALS LIMITED | $13.8K | 1 | 0.8% |
| 5 | STERILE INDIA PRIVATE LIMITED | $11.3K | 1 | 0.6% |
| 6 | STANEX DRUGS AND CHEMICALS PRIVATE LIMITED | $5.5K | 1 | 0.3% |
| 7 | AMPLICON BIOTECH | $698 | 3 | 0.0% |
| 8 | PROGENBIOLAB TECHNOLOGIES PRIVATE LIMITED | $136 | 1 | 0.0% |
| 9 | THEMIS MEDICARE LIMITED | $19 | 2 | 0.0% |
| 10 | NOVITIUM LABS PRIVATE LIMITED | $1 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Amino suppliers from CHINA to India include ZHEJIANG KANGLE PHARMACEUTICAL CO LTD, ZHEJIANG KANGLE PHARMACEUTICAL CO., LTD, FRESENIUS KABI (SINGAPORE) PTE LTD.. The leading supplier is ZHEJIANG KANGLE PHARMACEUTICAL CO LTD with import value of $799.0K USD across 5 shipments. India imported Amino worth $1.8M USD from CHINA in total across 114 shipments.
India imported Amino worth $1.8M USD from CHINA across 114 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Amino sourced from CHINA include APOTEX RESEARCH PRIVATE LIMITED, FRESENIUS KABI INDIA PRIVATE LIMITED, BIO GENOMICS ASIA. The largest buyer is APOTEX RESEARCH PRIVATE LIMITED with $1.2M in imports across 8 shipments.
The total value of Amino imports from CHINA to India is $1.8M USD, across 114 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
114 Verified Shipments
15 suppliers, 10 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists